Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C027576 |
4-hydroxy-2-nonenal |
4-hydroxy-2-nonenal results in decreased expression of GATA3 mRNA | decreases expression | 12419474
|
C016583 |
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of GATA3 protein | increases activity | 16835749
|
C016583 |
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of GATA3 mRNA | increases expression | 16835749 16582591
|
C016583 |
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
Bungarotoxins inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of GATA3 protein] | decreases reaction|increases activity | 16835749
|
C016583 |
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
Mecamylamine inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of GATA3 protein] | decreases reaction|increases activity | 16835749
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of GATA3 mRNA | affects expression | 17562736
|
C430898 |
AGN 194204 |
AGN 194204 results in increased expression of GATA3 mRNA | increases expression | 16339527
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of GATA3 mRNA | affects expression | 16483693
|
C006632 |
arsenic trioxide |
arsenic trioxide inhibits the reaction [GATA3 protein binds to IL13 promoter] | affects binding|decreases reaction | 19080345
|
C006632 |
arsenic trioxide |
arsenic trioxide inhibits the reaction [GATA3 protein binds to KPNA2 protein] | affects binding|decreases reaction | 19080345
|
D019324 |
beta-Naphthoflavone |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of GATA3 mRNA | affects cotreatment|decreases expression | 18164116
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of GATA3 mRNA | decreases expression | 17944540
|
C002791 |
bismuth tripotassium dicitrate |
bismuth tripotassium dicitrate results in decreased expression of GATA3 mRNA | decreases expression | 15912405
|
C005961 |
bis(tri-n-butyltin)oxide |
bis(tri-n-butyltin)oxide results in increased expression of GATA3 mRNA | increases expression | 17553608
|
D002038 |
Bungarotoxins |
Bungarotoxins inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of GATA3 protein] | decreases reaction|increases activity | 16835749
|
D002038 |
Bungarotoxins |
Bungarotoxins inhibits the reaction [N'-nitrosonornicotine results in increased activity of GATA3 protein] | decreases reaction|increases activity | 16835749
|
D002038 |
Bungarotoxins |
Bungarotoxins inhibits the reaction [N'-nitrosonornicotine results in increased expression of GATA3 mRNA] | decreases reaction|increases expression | 16835749
|
C014347 |
decitabine |
[decitabine co-treated with trichostatin A] results in decreased expression of GATA3 mRNA | affects cotreatment|decreases expression | 17891453
|
D013759 |
Tetrahydrocannabinol |
SR 144528 inhibits the reaction [Tetrahydrocannabinol results in increased expression of GATA3 mRNA] | decreases reaction|increases expression | 14741435
|
D013759 |
Tetrahydrocannabinol |
Tetrahydrocannabinol results in increased expression of GATA3 mRNA | increases expression | 14741435
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of GATA3 mRNA | affects cotreatment|decreases expression | 18164116
|
D004391 |
Dust |
Dust results in increased expression of GATA3 mRNA | increases expression | 17805423
|
D007052 |
Ibuprofen |
Ibuprofen results in decreased expression of GATA3 mRNA | decreases expression | 17630191
|
C051890 |
irinotecan |
irinotecan metabolite results in decreased expression of GATA3 mRNA | decreases expression | 15956246
|
C051890 |
irinotecan |
irinotecan results in decreased expression of GATA3 mRNA | decreases expression | 15956246
|
D008464 |
Mecamylamine |
Mecamylamine inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of GATA3 protein] | decreases reaction|increases activity | 16835749
|
D008464 |
Mecamylamine |
Mecamylamine inhibits the reaction [N'-nitrosonornicotine results in increased activity of GATA3 protein] | decreases reaction|increases activity | 16835749
|
D008464 |
Mecamylamine |
Mecamylamine inhibits the reaction [N'-nitrosonornicotine results in increased expression of GATA3 mRNA] | decreases reaction|increases expression | 16835749
|
C008655 |
N'-nitrosonornicotine |
Bungarotoxins inhibits the reaction [N'-nitrosonornicotine results in increased activity of GATA3 protein] | decreases reaction|increases activity | 16835749
|
C008655 |
N'-nitrosonornicotine |
Bungarotoxins inhibits the reaction [N'-nitrosonornicotine results in increased expression of GATA3 mRNA] | decreases reaction|increases expression | 16835749
|
C008655 |
N'-nitrosonornicotine |
Mecamylamine inhibits the reaction [N'-nitrosonornicotine results in increased activity of GATA3 protein] | decreases reaction|increases activity | 16835749
|
C008655 |
N'-nitrosonornicotine |
Mecamylamine inhibits the reaction [N'-nitrosonornicotine results in increased expression of GATA3 mRNA] | decreases reaction|increases expression | 16835749
|
C008655 |
N'-nitrosonornicotine |
N'-nitrosonornicotine results in increased activity of GATA3 protein | increases activity | 16835749
|
C008655 |
N'-nitrosonornicotine |
N'-nitrosonornicotine results in increased expression of GATA3 mRNA | increases expression | 16582591 16835749
|
D010126 |
Ozone |
Ozone results in decreased expression of GATA3 mRNA | decreases expression | 17460151
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of GATA3 mRNA | affects binding|decreases expression|increases activity | 19710929
|
C116926 |
rofecoxib |
rofecoxib results in decreased expression of GATA3 mRNA | decreases expression | 17070997
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of GATA3 mRNA | decreases expression | 12634122
|
D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of GATA3 mRNA | increases expression | 18175754
|
C110630 |
SR 144528 |
SR 144528 inhibits the reaction [Tetrahydrocannabinol results in increased expression of GATA3 mRNA] | decreases reaction|increases expression | 14741435
|
D013619 |
Tacrine |
Tacrine results in increased expression of GATA3 mRNA | increases expression | 12832660
|
D013629 |
Tamoxifen |
ESR1 protein affects the reaction [GATA3 protein affects the susceptibility to Tamoxifen] | affects reaction|affects response to substance | 19084267
|
D013629 |
Tamoxifen |
Tamoxifen results in increased expression of GATA3 mRNA | increases expression | 19031437
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of GATA3 mRNA | increases expression | 18684927
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of GATA3 mRNA | increases expression | 17118196 17138961
|
C012589 |
trichostatin A |
[decitabine co-treated with trichostatin A] results in decreased expression of GATA3 mRNA | affects cotreatment|decreases expression | 17891453
|
C015559 |
trimellitic anhydride |
trimellitic anhydride results in increased expression of GATA3 mRNA | increases expression | 20219652
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.25 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.56 | 15322242 11752688 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.26 | 18287403 |
MESH:D058186 |
Acute Kidney Injury |
|
Ibuprofen |
4.19 | 6375363 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.85 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
4.55 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Ibuprofen |
4.55 | 10697514 |
MESH:D000236 |
Adenoma |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
10.38 | 16176798 |
MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
10.38 | 19389873 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
10.38 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
15.56 | 18056438 19052882 17162532 17620307 16434500 19061943 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
15.56 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
15.56 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.40 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.60 | 17306315 16712894 |
MESH:D000437 |
Alcoholism |
|
Mecamylamine |
5.41 | 20201817 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.38 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Ibuprofen |
6.56 | 18351690 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
6.56 | 15513908 |
MESH:D000544 |
Alzheimer Disease |
|
Tacrine |
6.56 | 12725862 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
4-hydroxy-2-nonenal |
8.12 | 10965797 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
Tetrahydrocannabinol |
8.12 | 15204022 |
MESH:D000707 |
Anaphylaxis |
|
Ibuprofen |
4.96 | 9532969 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.69 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.54 | 10982225 |
MESH:D001169 |
Arthritis, Experimental |
|
rofecoxib |
7.22 | 16690336 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
7.22 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
4.42 | 15570426 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
4.42 | 16292516 |
MESH:D001249 |
Asthma |
|
Ozone |
7.56 | 17854713 16373670 |
MESH:D001249 |
Asthma |
|
Tretinoin |
7.56 | 16456186 |
MESH:D001249 |
Asthma |
|
trimellitic anhydride |
7.56 | 16141432 |
MESH:D050197 |
Atherosclerosis |
|
Tetrahydrocannabinol |
4.30 | 15815632 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.45 | 18445737 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.12 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
19.78 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
19.78 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
19.78 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
19.78 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.49 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.58 | 15746008 |
MESH:D002545 |
Brain Ischemia |
|
Ibuprofen |
4.59 | 15837124 |
MESH:D001943 |
Breast Neoplasms |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
2.81 | 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.81 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.81 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.81 | 21152245 16202921 19244106 18821012 20859285 20065188 17242785 18997820 19103187 18855134 20005174 18629630 19059307 19011961 17440819 19084267 19410462 20544844 19200415 11161223 19289846 19189212 19066611 19155303 17261762 19189210 20390343 18351453 19288272 19142967 17049068 19115204 16873071 17893378 19487384 18815881 16818667 15565566 18984771 19221464 18425577 15668708 21138602 20135344 16273361 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.81 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.81 | 16443354 16166294 16873071 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.45 | 19059883 18417511 14754758 17626835 16777450 18315731 15516495 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.29 | 16813970 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.06 | 11589617 |
MESH:D002100 |
Cachexia |
|
Ibuprofen |
11.58 | 15141370 |
MESH:D002100 |
Cachexia |
|
Ozone |
11.58 | 16183385 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.57 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.22 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.86 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
10.70 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
10.70 | 15553829 16217749 15073043 14691202 11135700 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
10.70 | 16569478 18978308 18691550 21159647 20432363 19519916 3084413 19822196 10672840 19418558 18788625 18665156 20727157 16807293 17055752 19383236 18494052 18971187 20101231 18785209 19208518 16779866 16878318 10737359 16502159 16830150 17761372 16540662 18210153 20512989 20214788 3581430 16328049 20007298 18056438 19335982 19052882 16698587 16935385 19394651 18393292 19107877 16681979 17162532 20514400 20084675 18506893 17138121 19701751 16288022 19919837 20935162 19171122 11831363 17978847 17428255 17173139 20524982 19539802 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
10.70 | 16507464 17306315 15276417 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
10.70 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
10.70 | 1917145 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.57 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.86 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
7.05 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
7.05 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
7.05 | 16096774 16051514 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.36 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.21 | 16120746 18670907 18850075 |
MESH:D002375 |
Catalepsy |
|
Tetrahydrocannabinol |
5.43 | 10318961 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
6.65 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
6.65 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
10.04 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
10.04 | 17174075 2727394 21159647 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
10.04 | 20056578 19524636 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.29 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
8.50 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
8.50 | 16835633 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.61 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.86 | 16461808 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.46 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.35 | 15668235 8697196 16354765 15340226 12621046 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.35 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.42 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
5.71 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
5.71 | 17725105 17287894 |
MESH:D003110 |
Colonic Neoplasms |
|
rofecoxib |
5.71 | 12902858 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
3.36 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
3.36 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
3.36 | 16303861 18259882 18509181 17159606 17454858 16391804 15273666 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.81 | 17141729 14669216 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.90 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
3.56 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.56 | 20055451 15322242 10048152 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.56 | 9224671 10589399 9211117 17551590 16925845 8800419 14991402 9125849 9142499 9664655 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.82 | 15213294 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.07 | 19031437 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.29 | 18249437 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.53 | 16285004 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
3.96 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
3.96 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.23 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
8.19 | 12705907 16081117 19370779 11461765 10774834 12958197 18713872 10915739 12540782 14725611 2444490 11287661 16393943 19739265 11739529 16781746 11743745 11834606 10663392 16109766 14550746 14986274 17562736 19085960 19923254 17906064 15619225 16227642 12392966 16177239 12153990 18071297 11529661 19416960 16485898 12594235 15968718 11421492 19420014 19164858 17522070 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
8.19 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
8.19 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.19 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.80 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.55 | 11462148 |
MESH:D004374 |
Ductus Arteriosus, Patent |
|
Ibuprofen |
5.32 | 16133044 18446180 18450898 |
MESH:D004487 |
Edema |
|
pirinixic acid |
5.68 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
5.68 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
10.94 | 15322242 16714409 18230668 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
10.94 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
3.26 | 19031437 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
13.03 | 19294695 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
trichostatin A |
13.03 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
6.80 | 16202921 19155303 17893378 20544844 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
6.80 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Ibuprofen |
14.04 | 15652904 |
MESH:D004715 |
Endometriosis |
|
rofecoxib |
14.04 | 15652904 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
14.04 | 9294722 10568697 |
MESH:D019446 |
Endotoxemia |
|
Ibuprofen |
4.67 | 11545620 |
MESH:D004827 |
Epilepsy |
|
Tetrahydrocannabinol |
4.33 | 821787 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.82 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.19 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
4.19 | 12903497 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.11 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.11 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
16.61 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
16.61 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
16.61 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
16.61 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.06 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.17 | 11858732 |
MESH:D005334 |
Fever |
|
Ibuprofen |
4.33 | 16997862 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.23 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.89 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
7.66 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
7.66 | 17994277 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.98 | 16904648 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.38 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.38 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
6.78 | 17312396 |
MESH:D005909 |
Glioblastoma |
|
trichostatin A |
6.78 | 18801729 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.29 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
7.17 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
7.17 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.86 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.02 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.02 | 9664655 14991402 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.36 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.07 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
7.30 | 19176532 18467677 19772884 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.30 | 16120746 15340226 12621046 |
MESH:D006689 |
Hodgkin Disease |
marker/mechanism |
|
| 21037568 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.91 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.75 | 16959395 8697196 18606429 15340226 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
6.86 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
6.86 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.28 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.93 | 20558911 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.80 | 18850075 18670907 |
MESH:D006984 |
Hypertrophy |
|
Ibuprofen |
4.71 | 16672835 |
OMIM:146255 |
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE |
marker/mechanism |
|
| |
MESH:D007035 |
Hypothermia |
|
Tetrahydrocannabinol |
5.63 | 10318961 |
MESH:D007235 |
Infant, Premature, Diseases |
|
Ibuprofen |
5.54 | 16133044 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
6.26 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.26 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
10.71 | 18785209 |
MESH:D007249 |
Inflammation |
|
Ibuprofen |
10.71 | 3291741 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
10.71 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
10.71 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
6.67 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
6.67 | 14714311 |
MESH:D007410 |
Intestinal Diseases |
|
rofecoxib |
9.18 | 15831440 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
9.18 | 17994277 |
MESH:D007417 |
Intestinal Polyps |
|
rofecoxib |
5.10 | 11245490 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.05 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.05 | 15992940 17551590 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
5.40 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
5.40 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
2.81 | 18625569 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
9.64 | 15070760 |
MESH:D007938 |
Leukemia |
|
decitabine |
9.64 | 19235587 18980019 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
9.64 | 17143497 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.53 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.01 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.21 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
14.47 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
14.47 | 17236224 19117987 18454857 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
14.47 | 16932348 16482212 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
8.30 | 16467208 16968895 19850784 20471514 17050201 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
8.30 | 18460780 18206229 17679729 19387464 19010910 18704418 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
8.30 | 17596541 16294345 19850784 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
trichostatin A |
8.30 | 18206229 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.16 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
7.00 | 16891316 15622746 15213294 19075265 17712046 12679006 17649720 16966277 12712474 17869043 19035177 15748426 11468182 19225113 16112521 15336539 16823087 16330433 9834237 12018890 17107899 16331271 19642359 11161223 17217047 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
7.00 | 16766008 17712046 17217047 16331271 15748426 19642359 19029980 19075265 16891316 17361223 17506722 17107899 17368321 16788101 16935935 17294898 17649720 19035177 16140955 9834237 17301526 16823087 19225113 17339181 12679006 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.07 | 16882451 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.10 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.95 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.66 | 20032147 18407596 18522880 19638242 18665156 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
6.32 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rofecoxib |
6.32 | 17565644 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
6.32 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.32 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
6.32 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
3.64 | 12969438 11587558 19014921 19460945 19784758 16611625 12587719 16610002 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
3.64 | 17034775 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
2.98 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
23.93 | 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
23.93 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
23.93 | 19389873 21295105 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
23.93 | 18648771 20583210 19426721 20492335 19638242 10737359 15885732 2862719 21278145 19090486 18644402 20434301 12771043 20405173 18977376 20118626 19499222 19427195 19294768 19850985 18754104 21071580 20452335 21167192 20101389 19642983 19254457 20501860 19812893 21047994 20137499 19833225 15175105 18978307 19256749 19255062 12112319 19073162 9163691 19996281 19690152 2422723 19551842 16942905 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
23.93 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
23.93 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
23.93 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
23.93 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
12.62 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
12.62 | 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
12.62 | 21159647 18079962 9362446 19004024 16842330 19009564 18308698 19539802 3124819 18775883 17854601 16267830 19126423 18544905 18093689 18253720 19519916 18164116 17174075 2563599 17942915 18282651 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
12.62 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.13 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
6.86 | 19066396 8266340 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
6.86 | 19095001 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.56 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
10.09 | 15893417 9255578 18508827 17139156 14755239 18813816 19931552 15172992 12438228 16401635 16061637 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
10.09 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
10.09 | 20512841 20970405 6695378 21163286 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
10.09 | 8597069 7614698 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
10.09 | 16712894 17077188 17306315 19931552 15276417 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
10.09 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
10.09 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.21 | 19470736 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
3.79 | 14737004 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.47 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Ibuprofen |
5.77 | 10697514 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
5.77 | 14580682 19196722 11731420 16827153 19196723 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.25 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.67 | 17453147 |
MESH:D008545 |
Melanoma |
|
decitabine |
9.19 | 16505122 17785578 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
9.19 | 16487513 19082730 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
9.19 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
9.19 | 16752155 |
MESH:D008545 |
Melanoma |
|
trichostatin A |
9.19 | 16505122 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.89 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.28 | 19513568 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.14 | 16940565 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.81 | 10496685 |
MESH:D052016 |
Mucositis |
|
irinotecan |
4.71 | 17159606 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
11.03 | 19417148 11468182 15949261 19549372 14977855 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
11.03 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
trichostatin A |
11.03 | 18172295 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.22 | 16239165 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.37 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
11.36 | 16882451 16105982 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
11.36 | 19157545 16882708 19010910 18608210 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
11.36 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.02 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.79 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.72 | 16411023 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.68 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
8.85 | 3581430 9029167 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
8.85 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
8.85 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.42 | 19410462 |
MESH:D009369 |
Neoplasms |
|
decitabine |
10.64 | 19116145 17925555 19470736 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
10.64 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
10.64 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
10.64 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.38 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.70 | 19189210 19196722 19200415 |
MESH:D009395 |
Nephritis, Interstitial |
|
Ibuprofen |
4.69 | 6375363 |
MESH:D009410 |
Nerve Degeneration |
|
Ibuprofen |
4.16 | 10961664 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
8.58 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
8.58 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
15.84 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
15.84 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tetrahydrocannabinol |
15.84 | 19040278 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
15.84 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
3.33 | 8761367 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
7.39 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
7.39 | 20387270 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
4.43 | 8761367 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.82 | 20387270 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.74 | 20558911 |
MESH:D010003 |
Osteoarthritis |
|
Ibuprofen |
7.71 | 7009135 |
MESH:D010003 |
Osteoarthritis |
|
rofecoxib |
7.71 | 16690336 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
13.95 | 19769630 16624393 12452020 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
13.95 | 19331143 19259094 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
13.95 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
13.95 | 16936753 |
MESH:D010051 |
Ovarian Neoplasms |
|
trichostatin A |
13.95 | 19331143 |
MESH:D010146 |
Pain |
|
Acetaminophen |
9.97 | 16870215 |
MESH:D010146 |
Pain |
|
Ibuprofen |
9.97 | 3291741 |
MESH:D010146 |
Pain |
|
Tretinoin |
9.97 | 16870215 |
MESH:D010149 |
Pain, Postoperative |
|
Ibuprofen |
10.74 | 16678543 |
MESH:D010149 |
Pain, Postoperative |
|
rofecoxib |
10.74 | 18165598 16678543 |
MESH:D010190 |
Pancreatic Neoplasms |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
23.19 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
23.19 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
23.19 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
23.19 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ibuprofen |
23.19 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
23.19 | 15976015 |
MESH:D010190 |
Pancreatic Neoplasms |
|
trichostatin A |
23.19 | 19294695 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.89 | 19927285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.95 | 12520081 |
MESH:D010538 |
Peritonitis |
|
Ozone |
3.84 | 16369182 |
MESH:D010787 |
Photosensitivity Disorders |
|
4-hydroxy-2-nonenal |
5.20 | 11550810 |
MESH:D011014 |
Pneumonia |
|
Ozone |
4.10 | 18929643 18381685 18007984 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.28 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.31 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
2.90 | 11896295 11118676 11399792 11222880 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
11.46 | 17616702 |
MESH:D055728 |
Primary Myelofibrosis |
|
trichostatin A |
11.46 | 17616702 |
MESH:D011471 |
Prostatic Neoplasms |
|
AGN 194204 |
2.06 | 16000583 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.06 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Ibuprofen |
2.06 | 17409433 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.06 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
2.06 | 18760546 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.06 | 15067354 |
MESH:D011471 |
Prostatic Neoplasms |
|
trichostatin A |
2.06 | 19789329 18798265 |
MESH:D011507 |
Proteinuria |
|
Ibuprofen |
8.60 | 6375363 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
8.60 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.50 | 16723453 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.24 | 19058328 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
trimellitic anhydride |
4.67 | 20219652 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.56 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
10.04 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
10.04 | 16116481 16283617 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
3.68 | 16646077 |
MESH:D012640 |
Seizures |
|
Mecamylamine |
4.55 | 12660363 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
8.61 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
8.61 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
8.61 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
3.99 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.74 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.57 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
7.89 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
7.89 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
7.89 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
7.89 | 15723263 |
MESH:D013274 |
Stomach Neoplasms |
|
N'-nitrosonornicotine |
7.89 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
7.89 | 17261132 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.60 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
15.29 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
15.29 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
15.29 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
15.29 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.53 | 16051514 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.67 | 15213294 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.05 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
10.97 | 20435036 11780464 12973940 12845720 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
10.97 | 19087683 17616700 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
10.97 | 16712894 16452187 17306315 11723127 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
10.97 | 16712894 8653321 17572228 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.71 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
8.56 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
8.56 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
11.83 | 17785578 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
11.83 | 16752155 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.13 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.29 | 12125929 |
MESH:D020301 |
Vasospasm, Intracranial |
|
Ibuprofen |
4.89 | 19057314 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.78 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.95 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.72 | 16287080 |